DMAAR

Drugs Made In Amer Acqutn Corp

• PUBT·05/14 21:05

  Drugs Made In America Acquisition swings to Q1 FY26 profit of $1.97 million

• PUBT·05/14 20:22

  Drugs Made in America Acquisition II swings to Q1 FY26 net income of $4.34 million

• PUBT·05/05 21:39

  Drugs Made In America Acquisition agrees to merge with Power Analytics Global in $1 billion deal

• PUBT·05/01 21:06

  Drugs Made In America Acquisition held shareholder meeting on extension amendment proposal

• PUBT·04/28 21:27

  Drugs Made in America Acquisition II sets CEO pay at $4,500 monthly, 250,000 shares

• PUBT·04/28 21:09

  Drugs Made In America Acquisition sets CEO pay at $4,500 monthly plus 250,000 shares

• PUBT·04/15 20:11

  Drugs Made in America Acquisition II posts FY25 net income of $4.2 million

• Reuters·04/08 13:03

  DRUGS MADE IN AMERICA ACQUISITION CORP SAYS DEAL ANTICIPATED TO VALUE POWER ANALYTICS GLOBAL CORP AT $1.0 BLN - SEC FILING

• Reuters·04/08 13:01

  Drugs Made In America Acquisition signs LOI to merge with Power Analytics Global at $1 billion valuation

• Reuters·04/03 20:34

  Drugs Made in America Acquisition II issues $1.4 million convertible notes financing deal

• Reuters·04/01 20:06

  Drugs Made In America Acquisition delays 10-K filing, targets April 15 submission

• Reuters·04/01 20:06

  Drugs Made in America Acquisition II delays annual report filing, targets April 15 deadline

• Reuters·03/27 20:58

  Drugs Made In America Acquisition Corp. announced an extraordinary general meeting

• Reuters·03/27 20:08

  Drugs Made In America Acquisition issued $100,000 interim convertible note to BV Advisory Partners; financing grows toward contemplated $500,000 total

• Reuters·03/17 20:02

  Drugs Made in America Acquisition II Corp. signs USD 150,000 unsecured convertible bridge note with Alpha Multi Family Office